Fisher & Paykel Healthcare Corporation Limited (NZE: FPH)

Market Cap	22.54B
Revenue (ttm)	1.89B
Net Income (ttm)	178.50M
Shares Out	586.12M
EPS (ttm)	0.30
PE Ratio	127.03
Forward PE	56.64
Dividend	0.42 (1.08%)
Ex-Dividend Date	Dec 5, 2024

Volume	349,919
Open	38.30
Previous Close	38.42
Day's Range	37.65 - 38.71
52-Week Range	22.55 - 39.21
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 21, 2024

About FPH

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1934
• Employees: 7,031
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: FPH

Financial Performance

In 2023, FPH's revenue was 1.74 billion, an increase of 10.23% compared to the previous year's 1.58 billion. Earnings were 132.60 million, a decrease of -47.02%.